Michigan Center First to Administer Controversial New Alzheimer’s Drug

Published on June 18, 2021

The first dose of the breakthrough, yet controversial, drug to treat Alzheimer’s disease took place Wednesday morning marking a pivotal turn in the fight against the disease. The Food and Drug Administration (FDA) approved Aduhelm, which is manufactured by Biogen, on June 7…

Read Full Article (External Site)